[Idiopathic thrombocytopenic purpura as first manifestation of systemic lupus erythematosus lupus]
- PMID: 10686711
[Idiopathic thrombocytopenic purpura as first manifestation of systemic lupus erythematosus lupus]
Abstract
Objectives: We studied SLE whose initial symptoms were related to idiopathic thrombocytopenic purpura (ITP) in order to determine if they share clinical and immunologic manifestations.
Methods: We reviewed the clinical backgrounds of 150 SLE (according to the ACR criteria) periodically followed from 1980 until 1998. We found 12 patients with both these conditions.
Results: All patients were female with a mean age of 32 at the time of ITP diagnosis and 36 at the time of SLE diagnosis. The most usual clinical manifestations were: arthritis (92%), cutaneous (58%) and hematologic involvement with lymphopenia (58%) and thrombocytopenia again (33%) after the initial ITP episode, always together with autoimmune hemolytic anemia (Evans syndrome). None of these patients presented with neurologic involvement and only one presented with renal involvement. 50% were positive for anti-DNA antibodies, 50% were Ro(+) and 16% were RNP (+). 66% were positive for antiphospholipid antibodies and 33% for lupus anticoagulant. Thrombocytopenia was controlled just with steroids in only 16% of the patients. Splenectomy controlled thrombocytopenia with complete remission achieved in 80% (4 from 5) of the patients and 20% (1 from 5) were refractory to this therapy after a medium follow-up time of 6.5 years.
Conclusions: 1) SLE whose initial symptoms are related to ITP were characterized by joints, cutaneous and hematologic involvement without renal and neurologic manifestations. 2) Splenectomy was able to control refractory thrombocytopenia in the majority of these patients.
Comment in
-
[Thrombocytopenia and lupus].An Med Interna. 1999 Dec;16(12):609-10. An Med Interna. 1999. PMID: 10686710 Review. Spanish. No abstract available.
Similar articles
-
Thrombocytopenic purpura as initial manifestation of systemic lupus erythematosus.J Rheumatol. 1997 May;24(5):867-70. J Rheumatol. 1997. PMID: 9150074
-
B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.Pediatrics. 2009 Jan;123(1):e159-63. doi: 10.1542/peds.2008-2361. Epub 2008 Dec 15. Pediatrics. 2009. PMID: 19074962
-
Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.Ann Hematol. 2002 Aug;81(8):436-40. doi: 10.1007/s00277-002-0488-x. Epub 2002 Jul 26. Ann Hematol. 2002. PMID: 12224000
-
Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature.Lupus. 2013 Jun;22(7):664-74. doi: 10.1177/0961203313485489. Epub 2013 Apr 23. Lupus. 2013. PMID: 23612795 Review.
-
[Immune thrombocytopenic purpura (ITP)].Orv Hetil. 2001 Dec 9;142(49):2723-30. Orv Hetil. 2001. PMID: 11883173 Review. Hungarian.
Cited by
-
Primary Immune Thrombocytopenic Purpura (ITP) and ITP Associated with Systemic Lupus Erythematosus: A Review of Clinical Characteristics and Treatment Modalities.Int J Rheumatol. 2024 Mar 1;2024:6650921. doi: 10.1155/2024/6650921. eCollection 2024. Int J Rheumatol. 2024. PMID: 38464849 Free PMC article. Review.
-
Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia.Arthritis Res Ther. 2022 Sep 6;24(1):213. doi: 10.1186/s13075-022-02901-y. Arthritis Res Ther. 2022. PMID: 36068638 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials